Miso, having another read of the GSK announcement do you think they may be infact looking at IV or nebulized Relenza? Alternative delivery systems may not mean a new "diskhaler"... it would be great to have a head start to Panamivir.
BTA Price at posting:
$1.38 Sentiment: Buy Disclosure: Held